Spinogenix Inc

Spinogenix Inc is a San Diego-based biotechnology company that is revolutionizing the field of neurodegenerative disease treatment. Their innovative approach focuses on regenerating synapses to restore memory and motor functions lost in conditions such as Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS). With their patent-protected compound, SPG302, Spinogenix aims to reverse the degenerative process and provide a game-changing solution for those suffering from neurodegenerative and psychiatric diseases.

Unlike other therapeutics that primarily aim to slow the progression of these conditions, Spinogenix's once-a-day tablet offers a unique mechanism of action to trigger the formation of new synaptic connections, effectively regenerating lost synapses. Their groundbreaking approach has garnered support from multiple NIH and DOD grant awards, positioning Spinogenix as a leader in the field of synaptic regenerative therapy. With ongoing human clinical studies and a commitment to making a difference in the lives of patients, Spinogenix is at the forefront of developing innovative treatments for neurodegenerative diseases.

Generated from the website